Matching trials
1,503 results
- (DECIDE)Complete statistical analysis of the phase 3 DECIDE trial comparing BIIB019 (daclizumab high yield process) with interferon beta-1a in participants with relapsing-remitting multiple sclerosis, including trial design, registered endpoints, regression methods, efficacy…
- 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): Complete Statistical AnalysisIndependent statistical analysis of 18-week add-on to Metformin Comparison of Saxagliptin and Sitagliptin in Adult Patients With Type 2 Diabetes (T2D): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 18F-AV-1451 Autopsy Study: Complete Statistical AnalysisIndependent statistical analysis of 18F-AV-1451 Autopsy Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02516046).
- 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: Complete Statistical AnalysisIndependent statistical analysis of 2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants: Complete Statistical AnalysisIndependent statistical analysis of 20-valent Pneumococcal Conjugate Vaccine Safety and Immunogenicity Study of a 4-Dose Series in Healthy Infants: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- 2CAREIndependent statistical analysis of Coenzyme Q10 in Huntington's Disease (HD): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00608881).
- 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis: Complete Statistical AnalysisIndependent statistical analysis of 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis: primary endpoint results, effect estimate with confidence interval,…
- 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of 3-year, Open-Label Study Evaluating Safety, Tolerability, and Efficacy of Lorecivivint in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- 306A/306BIndependent statistical analysis of A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 3CIndependent statistical analysis of Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01120028).
- 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period: Complete Statistical AnalysisIndependent statistical analysis of 52-week add-on to Metformin Comparison of Saxagliptin and Sulphonylurea, With a 52-week Extension Period: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- 65plusIndependent statistical analysis of Efficacy Study of Avastin® With Pemetrexed +/- Carboplatin to Treat Elderly Patients With Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- 68Ga PSMA in Preprostatectomy Patients: Complete Statistical AnalysisIndependent statistical analysis of 68Ga PSMA in Preprostatectomy Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03388346).
- A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.: Complete Statistical AnalysisIndependent statistical analysis of A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD…
- A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: Complete Statistical AnalysisIndependent statistical analysis of A 12-week Extension of the Phase III Study (D3820C00004) to Assess the Effect and Safety of NKTR-118 in Patients With Non-cancer-related Pain and Opioid-induced Constipation: primary endpoint results,…
- A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome: Complete Statistical AnalysisIndependent statistical analysis of A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children…
- A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: Complete Statistical AnalysisIndependent statistical analysis of A 3-Month Open-Label Safety and Efficacy Study of TNX-102 SL Tablets in Fibromyalgia Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): Complete Statistical AnalysisIndependent statistical analysis of A 3-month Study to Assess the Safety and Effectiveness of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: Complete Statistical AnalysisIndependent statistical analysis of A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A 6-Month Extension Study of OTO-104 in Meniere’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A 6-Month Extension Study of OTO-104 in Meniere's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02706730).
- A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A 6-month Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD): primary endpoint results, effect estimate…
- A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features: Complete Statistical AnalysisIndependent statistical analysis of A Cariprazine Study in the Prevention of Relapse in Bipolar I Disorder Patients Whose Current Episode is Manic or Depressive, With or Without Mixed Features: primary endpoint results,…
- A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus: primary endpoint results, effect estimate with confidence…
- A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial Comparing Efficacy And Safety Of Sunitinib And Capecitabine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial of Vorinostat (MK0683, SAHA) in Combination With FDA Approved Cancer Drugs in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)(0683-056): primary endpoint results, effect estimate…
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384): Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-384): primary endpoint results, effect estimate with confidence interval, sample-size…
- A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily, Ambroxol Hydrochloride 30 mg Twice Daily and Placebo…
- A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.: Complete Statistical AnalysisIndependent statistical analysis of A Clinical Trial Utilizing Dantrolene in Patients With Ventricular Arrhythmias.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04134845).
- A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient: Complete Statistical AnalysisIndependent statistical analysis of A Comparative Study Between Amlodipine 10mg And 5mg With Hypertension For Whom 5mg Is Insufficient: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis: Complete Statistical AnalysisIndependent statistical analysis of A Comparative Study Between PF-06410293 and Humira® in Combination With Methotrexate in Participants With Active Rheumatoid Arthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain: Complete Statistical AnalysisIndependent statistical analysis of A Comparative Study of JNS013 in Participants With Post-Tooth-Extraction Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00737048).
- A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis: Complete Statistical AnalysisIndependent statistical analysis of A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects With Chronic Obstructive Pulmonary Disease (COPD): Complete Statistical AnalysisIndependent statistical analysis of A Cross-Over Study to Evaluate Lung Function Response After Treatment With Umeclidinium (UMEC) 62.5 Micrograms (mcg), Vilanterol (VI) 25 mcg, and Umeclidinium/Vilanterol (UMEC/VI) 62.5/25 mcg Once-Daily in Subjects…
- A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn’s Disease: Complete Statistical AnalysisIndependent statistical analysis of A Dose-finding and Confirmatory Trial of OPC-6535 in Patients With Active Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea: Complete Statistical AnalysisIndependent statistical analysis of A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea:…
- A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures: Complete Statistical AnalysisIndependent statistical analysis of A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension: Complete Statistical AnalysisIndependent statistical analysis of A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size…
- A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Efficacy and Safety Study of Tramadol Hydrochloride Plus Acetaminophen (JNS013) in Japanese Participants With Chronic Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning…
- A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).: Complete Statistical AnalysisIndependent statistical analysis of A Long-Term Extension Study of WA22762 to Evaluate Safety and Efficacy of Subcutaneous Tocilizumab in Participants With Moderate to Severe Rheumatoid Arthritis (RA).: primary endpoint results, effect estimate…
- A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals’ Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su)…
- A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Safety Extension Study of Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD) in Multiple Sclerosis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP): Complete Statistical AnalysisIndependent statistical analysis of A Long-term Safety Study of Eltrombopag in Pediatric Patients With Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Long-term Safety Study of QMF149 in Japanese Participants With Asthma: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Safety Study of QMF149 in Japanese Participants With Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- A Long-term Trial of OPC-34712 in Patients With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of A Long-term Trial of OPC-34712 in Patients With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01456897).
- A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer: Complete Statistical AnalysisIndependent statistical analysis of A Maintenance Study With Niraparib Versus Placebo in Patients With Platinum Sensitive Ovarian Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle: Complete Statistical AnalysisIndependent statistical analysis of A Multi-Center, Evaluation of the Onset and Duration of Action of AC-170 0.24% Compared to Vehicle: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2): Complete Statistical AnalysisIndependent statistical analysis of A Multi-Site Phase 3 Study of MDMA-Assisted Psychotherapy for PTSD (MAPP2): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…